文献速递生殖医学

口服黄体酮黄体期支持提高来曲唑宫腔内人工授精周期活产率

Luteal phase support with oral progesterone improves live birth rate in intrauterine insemination cycles using letrozole.
PubMed 文献 · Reprod Biomed Online · 2024-05-09

本回顾性队列研究纳入2017年1月至2021年12月共1199个来曲唑宫腔内人工授精周期,采用倾向性评分匹配按1:2配对黄体期支持组与对照组。匹配后黄体期支持组427周期、对照组772周期,黄体期支持组活产率显著高于对照组(19.7% vs 14.5%,P=0.0255),临床妊娠率和持续妊娠率亦显著升高,但生化妊娠率、异位妊娠率、流产率及新生儿结局无显著差异。

要点

  • 来曲唑宫腔内人工授精周期中口服黄体酮黄体期支持可显著提高活产率(19.7% vs 14.5%,P=0.0255)。
  • 黄体期支持组临床妊娠率(23.2% vs 17.6%,P=0.0245)和持续妊娠率(20.6% vs 15.8%,P=0.0437)亦显著升高。
  • 两组生化妊娠率、异位妊娠率、流产率及新生儿出生体重、出生身长无显著差异(P>0.05)。

核心结论

  • 口服黄体酮黄体期支持显著提高来曲唑宫腔内人工授精周期的活产率,但不影响新生儿结局。

研究设计与样本

  • 回顾性队列研究,纳入2017年1月至2021年12月共1199个来曲唑宫腔内人工授精周期,采用最近邻随机匹配按1:2配对黄体期支持组与对照组。
  • 倾向性评分匹配模型纳入8个变量:年龄、体重指数、不孕年限、不孕原因、窦卵泡计数、基础FSH浓度、宫腔内人工授精尝试次数及主导卵泡大小。
  • 主要结局为活产率;匹配后黄体期支持组427周期,对照组772周期。

主要发现

  • 黄体期支持组活产率显著高于对照组(19.7% vs 14.5%,P=0.0255)。
  • 黄体期支持组临床妊娠率显著高于对照组(23.2% vs 17.6%,P=0.0245)。
  • 黄体期支持组持续妊娠率显著高于对照组(20.6% vs 15.8%,P=0.0437)。
  • 两组生化妊娠率、异位妊娠率及流产率相似(P>0.05)。
  • 两组间 gestational age、分娩方式、异位妊娠率或流产率无显著差异,出生体重和出生身长亦无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does luteal phase support (LPS) with oral progesterone improve the live birth rate (LBR) in patients undergoing intrauterine insemination (IUI) cycles with letrozole? DESIGN: This retrospective cohort study included 1199 IUI cycles with letrozole between January 2017 and December 2021. A nearest neighbour random matching approach was employed to pair the LPS group and the control group in a 1:2 ratio. Eight variables were chosen for matching in the propensity score matching (PSM) model: age; body mass index; duration of infertility; cause(s) of infertility; antral follicle count; basal concentration of FSH; rank of IUI attempts; and leading follicle size. LBR was selected as the primary outcome. RESULTS: In total, 427 LPS cycles were matched with 772 non-LPS (control) cycles after PSM. The LBR was significantly higher in the LPS group compared with the control group (19.7% versus 14.5%; P = 0.0255). The clinical pregnancy rate (23.2% versus 17.6%; P = 0.0245) and ongoing pregnancy rate (20.6% versus 15.8%; P = 0.0437) were also significantly higher in the LPS group. The biochemical pregnancy rate, ectopic pregnancy rate and miscarriage rate were similar in the two groups (P > 0.05). The intergroup comparison revealed no significant variances in terms of gestational age, mode of delivery, ectopic pregnancy rate or abortion rate. Furthermore, there were no significant differences in birth weight or birth length between the two groups. CONCLUSIONS: Luteal support with oral progesterone significantly improved the LBR in IUI cycles with letrozole, but did not affect neonatal outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Xi Q, Liao M, Wang Y, et al. Luteal phase support with oral progesterone improves live birth rate in intrauterine insemination cycles using letrozole. Reprod Biomed Online. 2024. PMID: 39047319. doi:10.1016/j.rbmo.2024.104077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。